However, in contrast to this recent report and consistent with our previously published study [5], unbiased screening and low-throughput target validation further emphasize that the MARCH5 ubiquitination machinery regulates apoptosis in AML cells largely in a NOXA-independent manner in the absence of venetoclax treatment. This evidence concerns the gene MARCHF5 and acute myeloid leukemia.